A phase III study to compare the efficacy and safety of paclitaxel versus irinotecan in patients with metastatic or recurrent gastric cancer who failed in first-line therapy (KCSG ST10-01)

Annals of Oncology ◽

10.1093/annonc/mdy282.064 ◽

2018 ◽

Vol 29 ◽

pp. viii228-viii229

Author(s):

K.-W. Lee ◽

C.H. Maeng ◽

T.-Y. Kim ◽

D.Y. Zang ◽

Y.H. Kim ◽

...

Keyword(s):

Gastric Cancer ◽

Phase Iii ◽

Efficacy And Safety ◽

First Line ◽

First Line Therapy ◽

Line Therapy ◽

Recurrent Gastric Cancer ◽

Phase Iii Study

Download Full-text

A Phase III Study to Compare the Efficacy and Safety of Paclitaxel Versus Irinotecan in Patients with Metastatic or Recurrent Gastric Cancer Who Failed in First‐line Therapy (KCSG ST10‐01)

The Oncologist ◽

10.1634/theoncologist.2018-0142 ◽

2018 ◽

Vol 24 (1) ◽

pp. 18 ◽

Cited By ~ 3

Author(s):

Keun‐Wook Lee ◽

Chi Hoon Maeng ◽

Tae‐You Kim ◽

Dae Young Zang ◽

Yeul Hong Kim ◽

...

Keyword(s):

Gastric Cancer ◽

Phase Iii ◽

Efficacy And Safety ◽

First Line ◽

First Line Therapy ◽

Line Therapy ◽

Recurrent Gastric Cancer ◽

Phase Iii Study

Download Full-text

Randomized multicenter phase III study of a modified docetaxel and cisplatin plus fluorouracil regimen compared with cisplatin and fluorouracil as first-line therapy for advanced or locally recurrent gastric cancer

Gastric Cancer ◽

10.1007/s10120-015-0457-4 ◽

2015 ◽

Vol 19 (1) ◽

pp. 234-244 ◽

Cited By ~ 41

Author(s):

Jinwan Wang ◽

Ruihua Xu ◽

Jian Li ◽

Yuxian Bai ◽

Tianshu Liu ◽

...

Keyword(s):

Gastric Cancer ◽

Phase Iii ◽

First Line ◽

First Line Therapy ◽

Multicenter Phase ◽

Line Therapy ◽

Recurrent Gastric Cancer ◽

Phase Iii Study ◽

Locally Recurrent

Download Full-text

Bevacizumab in Combination With Chemotherapy As First-Line Therapy in Advanced Gastric Cancer: A Randomized, Double-Blind, Placebo-Controlled Phase III Study

Yearbook of Oncology ◽

10.1016/j.yonc.2012.05.013 ◽

2012 ◽

Vol 2012 ◽

pp. 138-139 ◽

Cited By ~ 1

Author(s):

E.G. Chiorean

Keyword(s):

Gastric Cancer ◽

Advanced Gastric Cancer ◽

Phase Iii ◽

First Line ◽

Double Blind ◽

Double Blind Placebo ◽

First Line Therapy ◽

Line Therapy ◽

Phase Iii Study

Download Full-text

A phase III study to compare efficacy and safety of DHP107 (oral paclitaxel) versus IV paclitaxel in patients with metastatic or recurrent gastric cancer after failure of first-line chemotherapy (DREAM).

Journal of Clinical Oncology ◽

10.1200/jco.2015.33.15_suppl.tps4138 ◽

2015 ◽

Vol 33 (15_suppl) ◽

pp. TPS4138-TPS4138

Author(s):

Sang Cheul Oh ◽

Min-Hee Ryu ◽

Se Hoon Park ◽

Baek-Yeol Ryoo ◽

Sook Ryun Park ◽

...

Keyword(s):

Gastric Cancer ◽

Phase Iii ◽

Efficacy And Safety ◽

First Line ◽

Recurrent Gastric Cancer ◽

Phase Iii Study ◽

Line Chemotherapy ◽

Oral Paclitaxel

Download Full-text

Faculty Opinions recommendation of Bevacizumab in combination with chemotherapy as first-line therapy in advanced gastric cancer: a biomarker evaluation from the AVAGAST randomized phase III trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717548131.793003144 ◽

2012 ◽

Author(s):

Ian Beales

Keyword(s):

Gastric Cancer ◽

Advanced Gastric Cancer ◽

Phase Iii ◽

First Line ◽

Phase Iii Trial ◽

First Line Therapy ◽

Line Therapy ◽

Biomarker Evaluation

Download Full-text

6519 ORAL Favorable benefit to risk profile for pemetrexed plus cisplatin versus gemcitabine plus cisplatin in a large phase III study of first-line therapy in advanced non-small cell lung cancer

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(07)71347-2 ◽

2007 ◽

Vol 5 (4) ◽

pp. 363 ◽

Cited By ~ 2

Author(s):

G. Scagliotti ◽

K. Park ◽

S. Patil ◽

J. Rolski ◽

T. Gorksel ◽

...

Keyword(s):

Lung Cancer ◽

Risk Profile ◽

Small Cell ◽

Phase Iii ◽

Small Cell Lung ◽

First Line ◽

First Line Therapy ◽

Line Therapy ◽

Phase Iii Study ◽

Large Phase

Download Full-text

Randomized phase III study comparing the efficacy and safety of irinotecan plus S-1 with S-1 alone as first-line treatment for advanced gastric cancer (study GC0301/TOP-002)

Gastric Cancer ◽

10.1007/s10120-011-0009-5 ◽

2011 ◽

Vol 14 (1) ◽

pp. 72-80 ◽

Cited By ~ 97

Author(s):

Hiroyuki Narahara ◽

Hiroyasu Iishi ◽

Hiroshi Imamura ◽

Akira Tsuburaya ◽

Keisho Chin ◽

...

Keyword(s):

Gastric Cancer ◽

Advanced Gastric Cancer ◽

Phase Iii ◽

Line Treatment ◽

Efficacy And Safety ◽

First Line ◽

Cancer Study ◽

Gastric Cancer Study ◽

Phase Iii Study ◽

First Line Treatment

Download Full-text

A Randomized, Controlled Phase III Trial of Docetaxel, Cisplatin and Fluorouracil (DCF) versus Cisplatin Plus Fluorouracil (CF) as First-Line Therapy in Chinese advanced Gastric Cancer

Annals of Oncology ◽

10.1016/s0923-7534(20)33266-x ◽

2012 ◽

Vol 23 ◽

pp. ix231

Author(s):

L. Shen ◽

R. Xu ◽

J. Wang ◽

Y. Bai ◽

T. Liu ◽

...

Keyword(s):

Gastric Cancer ◽

Advanced Gastric Cancer ◽

Phase Iii ◽

First Line ◽

Phase Iii Trial ◽

Randomized Controlled ◽

First Line Therapy ◽

Line Therapy

Download Full-text

PROPEL: A randomized phase III trial evaluating the efficacy and safety of olaparib combined with abiraterone as first-line therapy in patients with metastatic castration-resistant prostate cancer (mCRPC)

European Urology Supplements ◽

10.1016/s1569-9056(19)31321-1 ◽

2019 ◽

Vol 18 (1) ◽

pp. e1824

Author(s):

N.W. Clarke ◽

A.J. Armstrong ◽

A. Thiery-Vuillemin ◽

M. Oya ◽

D. Ye ◽

...

Keyword(s):

Prostate Cancer ◽

Phase Iii ◽

Efficacy And Safety ◽

Castration Resistant Prostate Cancer ◽

First Line ◽

Phase Iii Trial ◽

First Line Therapy ◽

Castration Resistant ◽

Line Therapy

Download Full-text

Phase III study of taxane chemotherapy with lapatinib or trastuzumab as first-line therapy for women with HER2/neu-positive metastatic breast cancer (BC) (NCIC Clinical Trials Group (NCICCTG)MA.31/GSK EGF 108919).

Journal of Clinical Oncology ◽

10.1200/jco.2011.29.15_suppl.tps108 ◽

2011 ◽

Vol 29 (15_suppl) ◽

pp. TPS108-TPS108 ◽

Cited By ~ 3

Author(s):

W. Parulekar ◽

J. W. Chapman ◽

S. Aparicio ◽

Y. Murray ◽

F. M. Boyle ◽

...

Keyword(s):

Breast Cancer ◽

Clinical Trials ◽

Metastatic Breast Cancer ◽

Metastatic Breast ◽

Phase Iii ◽

First Line ◽

First Line Therapy ◽

Line Therapy ◽

Phase Iii Study ◽

Taxane Chemotherapy

Download Full-text